Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3451)

[41]

Müller, H.; Lukáš, J.; Schneider, A.; Warthoe, P.; Bártek, J.; Eilers, M.; Strauss, M.

Cyclin-D1 expression is regulated by the retinoblastoma protein

[year of publication 2006, impact factor 10.667]

[42]

Satoh, T.; Satoh, H.; Iwahara, S.I.; Hrkal, Z.; Peyton, D.H.; Muller-Eberhard, U.

Roles of heme iron-coordinating histidine residues of human hemopexin expressed in baculovirus-infected insect cells

[year of publication 2006, impact factor 10.667]

[43]

Peslova, G.; Petrak, J.; Kuzelova, K.; Hrdy, I.; Halada, P.; Kuchel, P.W.; Soe-Lin, S.; Ponka, P.; Sutak, R.; Becker, E.; Huang, M.L.-H.; Rahmato, Y.S.; Richardson, D.R.; Vyoral, D.

Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood

[year of publication 2009, impact factor 10.555]

[44]

Lukas, J.; Bartkova, J.; Rohde, M.; Strauss, M.; Bartek, J.

Cyclin D1 is dispensable for G(1) control in retinoblastoma gene-deficient cells independently of cdk4 activity

[year of publication 2006, impact factor 10.498]

[45]

Goodeve, A.

Erratum: Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) (Blood (2007) 109 (112-121))

[year of publication 2012, impact factor 10.432 ]

[46]

Haberichter, S.L.; Castaman, G.; Budde, U.; Peake, I.; Goodeve, A.; Rodeghiero, F.; Federici, A.B.; Batlle, J.; Meyer, D.; Mazurier, C.; Goudemand, J.; Eikenboom, J.; Schneppenheim, R.; Ingerslev, J.; Vorlova, Z.; Habart, D.; Holmberg, L.; Lethagen, S.; Pasi, J.; Hill, F.G.H.; Montgomery, R.R.

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the european study: Molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)

[year of publication 2010, impact factor 10.432]

[47]

Castaman, G.; Lethagen, S.; Federici, AB.; Tosetto, A.; Goodeve, A.; Budde, U.; Batlle, J.; Meyer, D.; Mazurier, C.; Fressinaud, E.; Goudemand, J.; Eikenboom, J.; Schneppenheim, R.; Ingerslev, J.; Vorlova, Z.; Habart, D.; Holmberg, L.; Pasi, J.; Hill, F.; Peake, I.; Rodeghiero, F.

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

[year of publication 2010, impact factor 10.432]

[48]

Forestier, E.; Izraeli, S.; Beverloo, B.; Haas, O.; Pession, A.; Michalová, K.; Stark, B.; Harrison, C.J.; Teigler-Schlegel, A.; Johansson, B.

Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome : an iBFM-SG study

[year of publication 2008, impact factor 10.432]

[49]

Porkka, K.; Koskenvesa, P.; Lundán, T.; Rimpiläinen, J.; Mustjoki, S.; Smykla, R.; Wild, R.; Luo, R.; Arnan, M.; Brethon, B.; Eccersley, L.; Hjorth-Hansen, H.; Höglund, M.; Klamová, H.; Knutsen, H.; Parikh, S.; Raffoux, E.; Gruber, F.; Brito-Babapulle, F.; Dombret, H.; Duarte, R.F.; Elonen, E.; Paquette, R.; Zwaan, C.M.; Lee, F.Y.

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

[year of publication 2008, impact factor 10.432]

[50]

Ho, G.Y.F.; Burk, R.D.; Klein, S.; Kadish, A.S.; Chang, C.J.; Palan, P.; Basu, J.; Tachezy, R.; Lewis, R.; Romney, S.

Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia

[year of publication 2006, impact factor 10.165]

[51]

Kramarzova, K.; Stuchly, J.; Willasch, A.; Gruhn, B.; Schwarz, J.; Cermak, J.; Machova-Polakova, K.; Fuchs, O.; Stary, J.; Trka, J.; Boublikova, L.

Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences

[year of publication 2012, impact factor 10.164 ]

[52]

Curik, N.; Burda, P.; Vargova, K.; Pospisil, V.; Belickova, M.; Vlckova, P.; Savvulidi, F.; Necas, E.; Hajkova, H.; Haskovec, C.; Cermak, J.; Krivjanska, M.; Trneny, M.; Laslo, P.; Jonasova, A.; Stopka, T.

5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity

[year of publication 2012, impact factor 10.164 ]

[53]

Germing, U.; Lauseker, M.; Hildebrandt, B.; Symeonidis, A.; Cermak, J.; Fenaux, P.; Kelaidi, C.; Pfeilstöcker, M.; Nösslinger, T.; Sekeres, M.; Maciejewski, J.; Haase, D.; Schanz, J.; Seymour, J.; Kenealy, M.; Weide, R.; Lübbert, M.; Platzbecker, U.; Valent, P.; Götze, K.; Stauder, R.; Blum, S.; Kreuzer, K.-A.; Schlenk, R.; Ganser, A.; Hofmann, W.-K.; Aul, C.; Krieger, O.; Kündgen, A.; Haas, R.; Hasford, J.; Giagounidis, A.

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study

[year of publication 2012, impact factor 10.164 ]

[54]

Crawley, CH.; Szydlo, R.; Lalancette, M.; Bacigalupo, A.; Lange, A.; Brune, M.; Juliusson, G.; Nagler, A.; Gratwohl, A.; Passweg, J.; Komarnicki, M.; Vítek, A.; Mayer, J.; Zander, A.; Sierra, J.; Rambaldi, A.; Ringden, O.; Niederwieser, D.; Apperley, J.F.:

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia : an analysis of prognostic factors from the Chronic leukemia working party of the EBMT.

[year of publication 2006, impact factor 10.131]

[55]

Stauder, R.; Yu, G.; Koinig, K.A.; Bagguley, T.; Fenaux, P.; Symeonidis, A.; Sanz, G.; Cermak, J.; et al.

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

[year of publication 2018, impact factor 9.994 ]

[56]

Riedel, T.; Suttnar, J.; Brynda, E.; Houska, M.; Medved, L.; Dyr, J.E.

Fibrinopeptides A and B release in the process of surface fibrin formation.

[year of publication 2010, impact factor 9.898]

[57]

Soverini, S.; De Benedittis, C.; Machova Polakova, K.; Brouckova, A.; Horner, D.; Iacono, M.; Castagnetti, F.; Gugliotta, G.; Palandri, F.; Papayannidis, C.; Iacobucci, I.; Venturi, C.; Bochicchio, M.T.; Klamova, H.; Cattina, F.; Russo, D.; Bresciani, P.; Binotto, G.; Giannini, B.; Kohlmann, A.; Haferlach, T.; Roller, A.; Rosti, G.; Cavo, M.; Baccarani, M.; Martinelli, G.

Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

[year of publication 2013, impact factor 9.775 ]

[58]

Chigrinova, E.; Rinaldi, A.; Kwee, I.; Votavova, H.; et al.

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

[year of publication 2014, impact factor 9.775 ]

[59]

Malcovati, L.; Hellström-Lindberg, E.; Bowen, D.; Ades, L.; Čermák, J.; Del Canizo, C.; Della Porta, M.G.; Fenaux, P.; Gattermann, N.; Germing, U.; Jansen, J.H.; Mittelman, M.; Mufti, G.; Platzbecker, U.; Sanz, G.F.; Selleslag, D.; Skov-Holm, M.; Stauder, R.; Symeonidis, A.; Van De Loosdrecht, A.A.; De Witte, T.; Cazzola, M.

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

[year of publication 2013, impact factor 9.775 ]

[60]

Mrug, M.; Stopka, T.; Prchal, J.F.; Prchal, J.T.

Angiotensin II stimulates proliferation of normal early erythroid progenitors

[year of publication 2006, impact factor 9.667]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 208

Deputy head of Science and Research Division
Tel:+420 221 977 269
Tel:+420 221 977 364

Secretary
Tel:+420 221 977 247


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here